Andrea Pfeifer
AC Immune (Switzerland)(CH)
Publications by Year
Research Areas
Alzheimer's disease research and treatments, Cholinesterase and Neurodegenerative Diseases, Computational Drug Discovery Methods, Neuroinflammation and Neurodegeneration Mechanisms, Neuroscience and Neuropharmacology Research
Most-Cited Works
- → An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A Binding Properties Promotes Neuroprotection and Glial Engulfment of A(2012)306 cited
- → Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy(2013)249 cited
- → Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies(2019)221 cited
- → Tau PET imaging with 18F-PI-2620 in Patients with Alzheimer Disease and Healthy Controls: A First-in-Humans Study(2019)198 cited
- → Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice(2007)174 cited
- → Aβ42 Neurotoxicity Is Mediated by Ongoing Nucleated Polymerization Process Rather than by Discrete Aβ42 Species(2010)172 cited
- → Antibody-Mediated Targeting of Tau In Vivo Does Not Require Effector Function and Microglial Engagement(2016)131 cited
- → The α-synuclein PET tracer [18F] ACI-12589 distinguishes multiple system atrophy from other neurodegenerative diseases(2023)126 cited
- → Structure of Crenezumab Complex with Aβ Shows Loss of β-Hairpin(2016)118 cited
- → Antibody semorinemab reduces tau pathology in a transgenic mouse model and engages tau in patients with Alzheimer’s disease(2021)106 cited